Advanced Enzyme Technologies Limited Asset Resilience Ratio
Advanced Enzyme Technologies Limited asset resilience ratio. Advanced Enzyme Technologies Limited (ADVENZYMES) has an Asset Resilience Ratio of 31.75% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Advanced Enzyme Technologies Limited fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Advanced Enzyme Technologies Limited (2008–2026)
Asset resilience ratio of Advanced Enzyme Technologies Limited from 2008 to 2026. This chart shows how Advanced Enzyme Technologies Limited's Asset Resilience Ratio has changed over time. Read ADVENZYMES current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Advanced Enzyme Technologies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ADVENZYMES total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs5.84 Billion | 31.75% |
| Total Liquid Assets | Rs5.84 Billion | 31.75% |
Asset Resilience Insights
- Very High Liquidity: Advanced Enzyme Technologies Limited maintains exceptional liquid asset reserves at 31.75% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Advanced Enzyme Technologies Limited Industry Peers by Asset Resilience Ratio
Compare Advanced Enzyme Technologies Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hengyi Petrochemical Co Ltd
SHE:000703 |
Specialty Chemicals | 0.06% |
|
Akzo Nobel NV
AS:AKZA |
Specialty Chemicals | 2.16% |
|
LB Group Co Ltd
SHE:002601 |
Specialty Chemicals | 4.81% |
|
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390 |
Specialty Chemicals | 0.39% |
|
Cngr Advanced Material Co Ltd
SHE:300919 |
Specialty Chemicals | 0.52% |
|
Qingdao Gon Technology Co Ltd
SHE:002768 |
Specialty Chemicals | 0.01% |
|
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240 |
Specialty Chemicals | 0.00% |
|
Borregaard ASA
OL:BRG |
Specialty Chemicals | 0.98% |
Advanced Enzyme Technologies Limited Asset Resilience Ratio by Year (2008–2026)
Advanced Enzyme Technologies Limited asset resilience ratio by year from 2008 to 2026. The table below shows the annual Asset Resilience Ratio data for Advanced Enzyme Technologies Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 31.75% | Rs5.84 Billion ≈ $63.14 Million |
Rs18.39 Billion ≈ $198.86 Million |
-1.99pp |
| 2025-03-31 | 33.74% | Rs5.47 Billion ≈ $59.16 Million |
Rs16.21 Billion ≈ $175.34 Million |
+0.79pp |
| 2024-03-31 | 32.95% | Rs5.06 Billion ≈ $54.72 Million |
Rs15.35 Billion ≈ $166.05 Million |
+3.22pp |
| 2023-03-31 | 29.73% | Rs4.23 Billion ≈ $45.72 Million |
Rs14.22 Billion ≈ $153.77 Million |
+14.73pp |
| 2022-03-31 | 15.00% | Rs1.90 Billion ≈ $20.56 Million |
Rs12.68 Billion ≈ $137.09 Million |
-2.44pp |
| 2021-03-31 | 17.43% | Rs2.01 Billion ≈ $21.73 Million |
Rs11.53 Billion ≈ $124.66 Million |
+1.34pp |
| 2020-03-31 | 16.09% | Rs1.57 Billion ≈ $17.03 Million |
Rs9.79 Billion ≈ $105.83 Million |
-0.63pp |
| 2019-03-31 | 16.72% | Rs1.36 Billion ≈ $14.67 Million |
Rs8.11 Billion ≈ $87.72 Million |
+8.11pp |
| 2018-03-31 | 8.61% | Rs629.94 Million ≈ $6.81 Million |
Rs7.32 Billion ≈ $79.12 Million |
+7.24pp |
| 2017-03-31 | 1.37% | Rs78.73 Million ≈ $851.44K |
Rs5.77 Billion ≈ $62.35 Million |
+5.37pp |
| 2016-03-31 | -4.01% | Rs-180.44 Million ≈ $-1.95 Million |
Rs4.51 Billion ≈ $48.72 Million |
-0.15pp |
| 2015-03-31 | -3.86% | Rs-160.34 Million ≈ $-1.73 Million |
Rs4.16 Billion ≈ $44.98 Million |
+0.33pp |
| 2014-03-31 | -4.19% | Rs-170.05 Million ≈ $-1.84 Million |
Rs4.06 Billion ≈ $43.92 Million |
-4.19pp |
| 2013-03-31 | 0.00% | Rs-2.00K ≈ $-21.61 |
Rs3.96 Billion ≈ $42.83 Million |
-0.16pp |
| 2010-03-31 | 0.16% | Rs1.76 Million ≈ $19.03K |
Rs1.09 Billion ≈ $11.80 Million |
+0.13pp |
| 2009-03-31 | 0.03% | Rs280.00K ≈ $3.03K |
Rs940.41 Million ≈ $10.17 Million |
-0.09pp |
| 2008-03-31 | 0.12% | Rs1.13 Million ≈ $12.22K |
Rs906.55 Million ≈ $9.80 Million |
-- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain… Read more